top of page

Divyalakshmi Ramakrishna, MDS

Content writer – Clinical

Divyalakshmi is a Clinical Content Writer at Rhenix. She is responsible for writing scientific content on healthcare-related topics. She also focuses on writing scientific white papers and review articles focusing on various fields of medicine and healthcare with the main focus on oncology, neurology, and immunology.

Divyalakshmi has a Master’s degree in Dental Surgery (MDS) from the Rajiv Gandhi Institute of Health Sciences. Before joining Rhenix, she also worked as Associate Professor at D. A. Pandu Memorial R.V. Dental College and Hospital, Bangalore, India.

At Rhenix, she has attained operational as well as scientific writing experiences.

Stories

Summary "Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma."

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain cancer in adults. It accounts for about 60-70% of gliomas. The standard treatment regimen for GBM is tumor resection followed...

Glioblastoma Multiforme - DR.jpg

Summary "Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s disease."

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline. Alzheimer's disease is the most common cause of dementia...

Alzheimer's disease.jpg

Summary "Prognostic factors associated with survival in patients with diffuse astrocytoma."

Astrocytomas are the most common primary tumors in the central nervous system (CNS). These tumors arise from astrocytes—star-shaped cells that make up the “glue-like” or supportive tissue of the brain. The diagnosis is based...

Astrocytoma.jpg

Summary "A molecularly integrated grade for meningioma."

Meningiomas are one of the most common primary intracranial tumors in adults. As there is the presence of more number of cases worldwide, there is a need for a reliable, widely accessible, and acceptable predictor of...

Meningioma.jpg

Videos

Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma | CellTalk

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain cancer in adults. It accounts for about 60-70% of gliomas. The standard treatment regimen for GBM is tumor resection followed by radiotherapy and...

Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s disease | CellTalk

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline. Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral...

Prognostic factors associated with survival in patients with diffuse astrocytoma | CellTalk

Astrocytomas are the most common primary tumors in the central nervous system (CNS). These tumors arise from astrocytes—star-shaped cells that make up the “glue-like” or supportive tissue of the brain. The diagnosis is based primarily on histopathological...

A molecularly integrated grade for meningioma | CellTalk

Meningiomas are one of the most common primary intracranial tumors in adults. As there is a presence of more number of cases worldwide, there is a need for a reliable, widely accessible, and acceptable predictor of clinical outcome after a...

Connecting Dots

Get the latest updates

Join Celltalk!

Subscribe us today & receive latest updates on your mail !

bottom of page